The trial of the criminal case involving the drug “Doc-1 Max,” was suspended starting from December 1 for a period of one month

The trial of the criminal case involving the drug "Doc-1 Max," ongoing since August of this year in the Tashkent city court, was today suspended starting from December 1 for a period of one month. Aziz Abidov, the spokesperson for the Supreme Court, informed the public about this development.

The decision to suspend the trial was made on December 1, 2023, under Article 416 of the Code of Criminal Procedure, pertaining to court actions when determining the grounds for prosecuting the defendant on a new charge, and Article 417, which addresses court actions when determining circumstances indicating that a crime has been committed by a person who has not been held criminally responsible. A ruling was issued, and certain documents related to the criminal case, specifically those pertaining to filling in the accusation and involving other individuals as accused, were sent to the investigative body for further procedural actions.

As a result, the investigation of the criminal case has been halted for a period of one month, according to the report.
"Dok-1 Max" Case:

The Ministry of Health of the Republic of Uzbekistan reported that the "Dok-1 Max" syrup, manufactured by the Indian pharmaceutical company Marion Biotech, led to the deaths of 20 children in Uzbekistan. Subsequently, the ministry did not provide any further statements on the incident. However, by August of this year, the press service of the Supreme Court revealed that the number of children who died due to poisoning from "Dok-1 Max" syrup was not 20, but 65, as reported by the Ministry of Health.

Further investigations revealed that Marion Biotech had used a toxic substance intended for industrial use in the production of drugs.

Following this, the Investigative Department of the State Security Service initiated a criminal case against officials of "Kuramax Medical" LLC and "Scientific Center for Standardization of Medicines" LLC, leading to the placement of suspects in the State Security Service Investigation Detention Center.

The approved indictment charged a total of 21 individuals with various crimes, including tax evasion, production and sale of low-quality or counterfeit drugs, abuse of power, bribery, fraud, and forgery of documents, among others. Of the defendants, 16 are men and 5 are women, with 7 held in detention, 12 receiving a "receipt of good behavior," and 2 granted bail.

They were charged with 11 articles of the Criminal Code. These are:

1. Article 184 - evasion of payment of taxes or fees;
2. Article 28 - types of crime participants;
3. Article 186-3 – Production, preparation, acquisition, storage, transportation, or transfer of low-quality or counterfeit drugs or medical products, sale of drugs or medical products outside pharmacies and their branches, as well as in violation of the procedure for the retail sale of prescription drugs containing strong active substances;
4. Article 25 - preparation for a crime and attempt to commit a crime;
5. Article 205 - abuse of power or authority;
6. Article 207 - cold-hearted approach to a career;
7. Article 209 - career fraud;
8. Article 210 - bribery;
9. Article 211 - bribery;
10. Article 212 - mediation in giving and receiving bribes;
11. Article 228 - preparation of documents, stamps, seals, forms, their forgery, sale, or use.